Should statins be given routinely in all coronary patients?

Comment

Loukianos S Rallidis et al. Int J Cardiol. 2009.

. 2009 Jul 10;135(3):399-401.

doi: 10.1016/j.ijcard.2008.05.001. Epub 2008 Jun 20.

No abstract available

Comment on

The double-edged sword of statin immunomodulation.
Goldstein MR, Mascitelli L, Pezzetta F. Goldstein MR, et al. Int J Cardiol. 2009 Jun 12;135(1):128-30. doi: 10.1016/j.ijcard.2008.01.023. Epub 2008 May 16. Int J Cardiol. 2009. PMID: 18485499

The large clinical statin trials.
Agewall S. Agewall S. Int J Cardiol. 2011 Jul 1;150(1):108-11. doi: 10.1016/j.ijcard.2011.04.029. Epub 2011 May 28. Int J Cardiol. 2011. PMID: 21621286 Review. No abstract available.
Statins and heart failure.
Filippatos TD, Mikhailidis DP. Filippatos TD, et al. Angiology. 2008 Apr-May;59(2 Suppl):58S-61S. doi: 10.1177/0003319708319643. Epub 2008 May 28. Angiology. 2008. PMID: 18508847 Review.
High-density lipoprotein-dependent effects of statins on the risk of coronary heart disease deaths and events.
Takagi H, Matsui M, Umemoto T. Takagi H, et al. Int J Cardiol. 2011 Nov 3;152(3):377-9. doi: 10.1016/j.ijcard.2011.07.071. Epub 2011 Aug 17. Int J Cardiol. 2011. PMID: 21851993 Review. No abstract available.
A clinical focus on statins.
Auer J, Eber B. Auer J, et al. Curr Opin Investig Drugs. 2001 Mar;2(3):382-8. Curr Opin Investig Drugs. 2001. PMID: 11575709 Review.
What the statin trials have taught us.
Waters DD. Waters DD. Am J Cardiol. 2006 Jul 1;98(1):129-34. doi: 10.1016/j.amjcard.2006.01.066. Epub 2006 May 6. Am J Cardiol. 2006. PMID: 16784935